Hudson Bay Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-44,091
| Closed | -$4.1M | – | 1412 |
|
|
2021
Q4 | $4.1M | Sell |
44,091
-38,207
| -46% | -$2.52M | 0.04% | 413 |
|
|
2021
Q3 | $4.9M | Buy |
82,298
+37,298
| +83% | +$2.2M | 0.07% | 343 |
|
|
2021
Q2 | $3.07M | Buy |
+45,000
| New | +$2.93M | 0.04% | 496 |
|
|
2021
Q1 | – | Sell |
-30,000
| Closed | -$2.31M | – | 1047 |
|
|
2020
Q4 | $2.31M | Buy |
+30,000
| New | +$2.25M | 0.02% | 352 |
|
|
2020
Q3 | – | Sell |
-28,500
| Closed | -$1.79M | – | 667 |
|
|
2020
Q2 | $1.79M | Sell |
28,500
-1,500
| -5% | -$82.5K | 0.03% | 327 |
|
|
2020
Q1 | $1.26M | Buy |
30,000
+20,000
| +200% | +$917K | 0.03% | 303 |
|
|
2019
Q4 | $454K | Buy |
+10,000
| New | +$473K | 0.01% | 351 |
|
|
2018
Q4 | – | Sell |
-8,500
| Closed | -$391K | – | 967 |
|
|
2018
Q3 | $391K | Buy |
+8,500
| New | +$345K | ﹤0.01% | 631 |
|
|
2018
Q1 | – | Sell |
-160,000
| Closed | -$5.43M | – | 904 |
|
|
2017
Q4 | $5.43M | Sell |
160,000
-145,000
| -48% | -$4.13M | 0.12% | 148 |
|
|
2017
Q3 | $7.78M | Buy |
305,000
+240,000
| +369% | +$5.5M | 0.19% | 107 |
|
|
2017
Q2 | $1.1M | Buy |
+65,000
| New | +$891K | 0.02% | 398 |
|
Hudson Bay Capital Management's ARNA Position: Q1 2022 in Review
Hudson Bay Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 44,091 shares — an estimated $4.1M sold.
Hudson Bay Capital Management first reported a position in ARNA in Q2 2017 and held it in 11 quarters. The position peaked at $7.78M in Q3 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Hudson Bay Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Hudson Bay Capital Management sold 44,091 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.1M.
- Hudson Bay Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 11 quarters.
- Hudson Bay Capital Management's Arena Pharmaceuticals Inc position peaked at $7.78M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Hudson Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.